Nigeria’s pharmaceutical sector has emerged as one of the stock market’s strongest performers in 2025, with Fidson and May & Baker recording year-to-date gains of 117 percent and 86.2 percent, respectively, as of 16 September 2025.
In a market still navigating persistent inflation, curren
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
